Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00087880 · ClinicalTrials.gov registry record · Phase 2
Maintaining Abstinence in Chronic Cigarette Smokers - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 407
- Enrollment target
NCT00087880 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 407 participants.
The verdict
NCT00087880, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 407 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.
Interventions
- DRUG Bupropion and NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2002-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00087880
The ClinicalTrials.gov registry entry for NCT00087880 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 407 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupropion and NRT is the first listed.
NCT00087880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00087880 about?
NCT00087880 is a clinical study titled "Maintaining Abstinence in Chronic Cigarette Smokers - 1". The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.
What is the current status of trial NCT00087880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 407 participants. The study started on 2002-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00087880?
The interventions under investigation include: Bupropion and NRT (DRUG).
Who is sponsoring clinical trial NCT00087880?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.